Lymphocyte-to-C-Reactive Protein (LCR) Ratio Is Not Accurate to Predict Severity and Mortality in Patients with COVID-19 Admitted to the ED
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24065996 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Laure Abensur Vuillaume und 10 weiteren Autor:innen. Beteiligte Einrichtung: Emergency Department, CHR Metz-Thionville, 57000 Metz, France. Hauptthemen laut MEDLINE: COVID-19. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Health care systems worldwide have been battling the ongoing COVID-19 pandemic. Since the beginning of the COVID-19 pandemic, Lymphocytes and CRP have been reported as markers of interest. We chose to investigate the prognostic value of the LCR ratio as a marker of severity and mortality in COVID-19 infection. Between 1 March and 30 April 2020, we conducted a multicenter, retrospective cohort study of patients with moderate and severe coronavirus disease 19 (COVID-19), all of whom were hospitalized after being admitted to the Emergency Department (ED). We conducted our study in six major hospitals of northeast France, one of the outbreak’s epicenters in Europe. A total of 1035 patients with COVID-19 were included in our study. Around three-quarters of them (76.2%) presented a moderate form of the disease, while the remaining quarter (23.8%) presented a severe form requiring admission to the ICU. At ED admission, the median LCR was significantly lower in the group presenting severe disease compared to that with moderate disease (versus 6.24 (3.24–12) versus 12.63 ((6.05–31.67)), p < 0.001). However, LCR was neither associated with disease severity (OR: 0.99, CI 95% (0.99–1)), p = 0.476) nor mortality (OR: 0.99, CI 95% (0.99–1)). In the ED, LCR, although modest, with a threshold of 12.63, was a predictive marker for severe forms of COVID-19.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Emergency Department, CHR Metz-Thionville, 57000 Metz, France.
- Department of Public Health, University Hospital of Strasbourg, 67000 Strasbourg, France.
- Service SAMU-Urgences, Centre Hospitalier Universitaire Édouard Herriot, Hospices Civils de Lyon, 69000 Lyon, France.
- Department of Gynecologic Surgery, Hôpitaux Universitaires de Strasbourg, 67000 Strasbourg, France.
- Emergency Department, Hôpital Nord Franche Comté, 90400 Belfort, France.
- Emergency Department, Hôpitaux Universitaires de Strasbourg, 67000 Strasbourg, France.
ORCID-Profile: Laure Abensur Vuillaume, Axel Benhamed, Pierrick Le Borgne
Zitieren
APA
Abensur Vuillaume, L., Lefebvre, F., Benhamed, A., Schnee, A., Hoffmann, M., Godoy Falcao, F., Haber, N., Sabah, J., Lavoignet, C. E., Le Borgne, P., & CREMS Network (Clinical Research in Emergency Medicine and Sepsis) (2023). Lymphocyte-to-C-Reactive Protein (LCR) Ratio Is Not Accurate to Predict Severity and Mortality in Patients with COVID-19 Admitted to the ED. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24065996
Vancouver
Abensur Vuillaume L, Lefebvre F, Benhamed A, Schnee A, Hoffmann M, Godoy Falcao F, et al. Lymphocyte-to-C-Reactive Protein (LCR) Ratio Is Not Accurate to Predict Severity and Mortality in Patients with COVID-19 Admitted to the ED. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24065996
BibTeX
@article{AbensurVuillaume2023,
author = {Abensur Vuillaume, Laure and Lefebvre, François and Benhamed, Axel and Schnee, Amandine and Hoffmann, Mathieu and Godoy Falcao, Fernanda and Haber, Nathan and Sabah, Jonathan and Lavoignet, Charles-Eric and Le Borgne, Pierrick and CREMS Network (Clinical Research in Emergency Medicine and Sepsis), CREMS Network (Clinical Research in Emergency Medicine and Sepsis)},
title = {Lymphocyte-to-C-Reactive Protein (LCR) Ratio Is Not Accurate to Predict Severity and Mortality in Patients with COVID-19 Admitted to the ED},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24065996}
}
EUVIMED